Introduction
Diabetics have a significantly greater incidence and Ž . severity of angina, acute myocardial infarctions AMI , congestive heart failure, and other manifestations of w x atherosclerosis than the non-diabetic population 1-5 . Even in the absence of ischemic heart disease, impairment Ž . of ventricular performance diabetic cardiomyopathies can w x occur 1,6-9 . Although an increased incidence of atherosclerosis in diabetics contributes to these complications, population-based studies have shown that non-coronary w x factors are also important contributing factors 10 . As an example, the incidence and severity of complications associated with AMI are greater in the diabetic population even though the size of the infarct is not significantly different, and may even be smaller, compared to the non-diabetic w x population 11-13 . Diabetes-induced changes within the heart appear to be important contributing factors to injury w x during and following an AMI 7,10-12,14-18 . Both heart failure following an AMI and diabetic cardiomyopathies have been correlated with the acute metabolic status of the w x patient 12, 19 .
Although epidemiological data and clinical studies have convincingly demonstrated that the diabetic has increased susceptibility to ischemic injury, experimental studies are inconsistent in this regard, demonstrating both an increased or decreased sensitivity of the diabetic heart to ischemic injury. This review will make a case for the observation that the diabetic heart is less sensitive to ischemic injury and we will discuss potential subcellular mechanisms that may be responsible for this decreased sensitivity to ischemic injury. 
Experimental studies involving diabetes and myocardial ischemia
Although clinical evidence suggests that the diabetic heart is more sensitive to ischemic injury, experimental studies are divided on this issue. In vivo studies have not resolved this issue. In alloxan-induced diabetic dogs, w x Haider et al. 20 showed that occlusion of the left anterior descending coronary artery results in a greater decrease in stroke volume and work, as well as a greater rise in end-diastolic pressure and volume, than in control dogs. This occurs despite comparable size of the ischemic area.
However, in open-chested streptozotocin-induced diabetic rats, infarct size has been shown to be substantially reduced compared to control rats following a 35-45 min w x period of left coronary artery occlusion 21 .
Although in vivo studies investigating the effects of diabetes on severe ischemia are controversial, in vitro studies are more consistent in demonstrating that diabetic hearts are less susceptible to injury following a severe episode of ischemia. Prior to defending this statement, we feel it is important to point out that diabetic hearts can be more susceptible to ischemic injury if they are subjected to w mild ischemia, moderate ischemia, hypoxia or anoxia 22-x . 29 , see review by Dennis Paulson in this issue . It is also important to point out many of the studies which suggest that the diabetic heart is more sensitive to ischemic injury are measuring experimental parameters of injury during the actual ischemic period, as opposed to during reperfusion following ischemia. As will be discussed below, most of the studies showing that the diabetic heart is not more sensitive to ischemic injury have monitored the recovery of mechanical function following a severe ischemic episode. Confusing this issue further is the fact that most of the experimental studies which have addressed this topic have used widely differing experimental conditions. These studies not only have differences in the severity of ischemia, but also differences in the duration of the diabetes and the isolated heart perfusion conditions. This latter factor is important since the sensitivity of the diabetic heart to ischemia is related to the reliance of the heart w x on fatty acids as an energy substrate 27,28 . In this regard, many of the studies that have addressed the issue of the sensitivity of the diabetic heart to ischemic injury have not included fatty acids in the perfusion medium. It also needs to be recognized that all of the isolated heart studies that use crystalloid perfusion media do not reproduce the same environment as the blood-perfused heart seen in vivo. However, the importance of blood perfusion versus crystalloid perfusion in altering the sensitivity of the diabetic heart to ischemic injury has yet to be directly addressed.
A number of studies from various laboratories have shown that hearts from diabetic rats will recover to the same degree as non-diabetic hearts following an episode of w x no-flow or very-low-flow ischemia 30-34 . In fact, depending on the experimental conditions, the diabetic rat heart can actually be more resistant than non-diabetic w x hearts to an episode of severe ischemia 21,35-37 . Tani w x and Neely 35 showed that if isolated hearts from streptozotocin-diabetic rat hearts were subjected to a period of no-flow ischemia, recovery of function was significantly better than in non-diabetic hearts subjected to the same protocol. Similar results were also obtained from our labow x w x ratories 36,37 . A recent study by Liu et al. 21 has also demonstrated that diabetic rat hearts are more readily preconditioned than control hearts, suggesting that metabolic changes at the level of the myocardium can contribute to ischemic injury.
As pointed out, the issue of whether the diabetic heart is more resistant to a severe episode of ischemia is still controversial, and it should be noted that other investigators have demonstrated that the mechanical function of ischemic hearts from diabetic rats can be depressed during w x recovery from a severe ischemia 38,39 . A number of possible explanations have been proposed as to why the myocardium of the diabetic is more sensitive to ischemic Ž . injury see accompanying paper by D. Paulson . An increased susceptibility to free radicals and eicosanoid-mediated injury are two mechanisms which have been proposed w x 2 q 38,39 . Alterations in control of intracellular pH and Ca handling may also be important. However, as will be discussed, alterations in the latter two parameters may in fact decrease the sensitivity of the diabetic heart to isw x chemic injury 35 .
Effects of diabetes on energy substrate use in the ischemic and reperfused ischemic heart
Myocardial energy substrate utilization by the heart is a highly regulated process which is primarily controlled by the energy demand of the muscle and the energy substrate supply to the heart. Normally, fatty acids and glucose are the primary energy substrates of the heart, with fatty acids accounting for 50-70% of the total oxygen consumption. In diabetes, however, glucose utilization is markedly reduced and fatty acids account for 90-99% of the total Ž myocardial oxygen consumption see review by Stanley et . al. in this issue . One reason for this decrease in glucose utilization is a decrease in insulin-dependent glucose uptake. Another key reason for the decreased use of glucose is the inhibition of glycolytic flux and glucose oxidation due to increased circulating and endogenous levels of fatty w x acids 40,41 . Use of fatty acids for mitochondrial oxidative metabolism results in a marked decrease in both pyruvate dehydrogenase activity, the first irreversible reaction in the mitochondrial oxidation of glucose, and phosphofructokinase activity, the rate-limiting step in glycolyw x sis 41 . Inhibition of pyruvate dehydrogenase by fatty acids is primarily due to an increase in the intramitochonw x drial acetyl CoArCoA ratio 40,41 . Inhibition of phosphofructokinase activity by fatty acids is primarily medi-( )w x ated by an increase in citrate levels 42 and a decrease in w x fructose 2,6-bisphosphate levels 43 .
During ischemia, oxidative metabolism of fatty acids and glucose decreases with a concomitant increase in glycolysis. It has long been recognized that anaerobic glycolysis can provide an important source of ATP produc-Ž w x . tion in ischemic myocardium see Ref. 44 for review . However, a number of studies have challenged the theory that increasing glycolysis during the actual ischemic event w x is beneficial. Neely and Grotoyohann 45 demonstrated that accumulation of glycolytic products in situations of very-low-flow or no-flow ischemia may actually be detrimental to the heart. Accumulation of lactate, and the accompanying decrease in myocardial pH may contribute w x to myocardial cell injury 45 . Furthermore, decreasing glycolysis by depleting the myocardial glycogen pool prior to ischemia results in a decrease in lactate accumulation during ischemia, and an enhanced recovery of mechanical function during reperfusion. Studies both supporting and refuting the involvement of glycolytic products have ap-Ž peared in the literature since this initial report see Ref. w x . 30 for review . This issue is relevant to diabetes, since marked changes in glycolysis occur in the diabetic heart w x 29,46,47 . In this setting of severe ischemia it is possible that decreased glycolytic rates may actually be beneficial to the heart. Glycolytic rates during ischemia are also dependent on the levels of glycogen in the heart prior to ischemia. However, the issue of whether pre-ischemic glycogen levels are beneficial or detrimental to the outcome of isw x chemic injury is controversial 45,48 . Whether high glycogen pre-ischemia contributes to ischemic injury appears to depend on the severity of ischemic injury, with low glycogen levels being beneficial if hearts are subjected to a severe no-flow ischemia. These low levels of glycogen will decrease the potential for glycolytic product accumulation during an episode of severe ischemia. The relationship between pre-ischemic glycogen levels in the diabetic rat heart and ischemic injury has yet to be clearly established. Pre-ischemic glycogen levels can be elevated in the w x diabetic rat heart. A recent study by Higuchi et al. 49 has Ž shown that in chronically streptozotocin-diabetic rats 6 . weeks duration glycogen levels are approximately twice the levels seen in control hearts or diabetic rats of 1-week duration. If hearts were subjected to low-flow ischemia, during the first 20 min of ischemia diastolic tension was less in the 6-week than in the 1-week diabetic rats. However, at the end of 60 min of underperfusion diastolic tension increased twice as much. These authors concluded that high glycogen helps delay the onset of injury, but that the degree of injury depends on the duration of diabetes.
When looking at the sensitivity of hearts to ischemic injury, it is important to consider the experimental conditions chosen to study glycolytic product accumulation during ischemia. Of importance is the fact that high levels of fatty acids markedly decrease myocardial glucose utilization. If hearts are perfused with physiological concentrations of fatty acids a 12-fold decrease in glucose utilization under aerobic conditions occurs compared to rates w x seen in hearts perfused in the absence of fatty acids 50 . In hearts perfused in the presence of relevant concentrations of fatty acids, glycolytic product enhancement of ischemic injury may only become important if glucose use is markedly stimulated, such as is seen if hearts are perfused Ž w
While serum fatty acid concentrations in normal individuals range from 0.2-0.5 mM, during an acute myocar-Ž . dial infarction AMI , or during cardiac bypass surgery, w x serum fatty acids can increase above 1 mM 51-54 . In both instances this increase can occur very rapidly, and in patients undergoing elective cardiac bypass surgery the increase in fatty acids can occur even before the onset of w x myocardial ischemia 54 . In diabetics serum fatty acids can be elevated even in the absence of an AMI. We have recently observed that levels in poorly controlled diabetics w suffering an AMI can exceed 2 mM Davies and x Lopaschuk, unpublished observations . The increase in fatty acids in both diabetics and non-diabetics during an AMI appears to result primarily from catecholamine stimulation of adipocyte tissue lipolysis. Several investigators have suggested an association between serum fatty acid Ž levels and adverse outcomes in AMI patients including clinical left ventricular failure, malignant ventricular ar-
. w x rhythmias, and death 51-53 . A number of experimental studies have examined the involvement of fatty acids during ischemia, and possible mechanisms by which fatty acids contribute to injury. Fatty acids clearly promote and accelerate arrhythmias, decrease mechanical function, and impair membrane integrity and suborganelle performance Ž w x . see Ref. 30 for review . Even in the absence of diabetes, high levels of fatty acids can potentiate myocardial ischemic injury, which appears to be related to the effects of fatty acids on glucose utilization, both during ischemia and Ž w x during reperfusion following ischemia see Ref. 30 for . review . Our studies suggest that stimulation of glucose utilization during ischemia in diabetic rat hearts is more important than stimulation of glucose utilization following w x ischemia 27-29 . In particular, during low-flow or no-flow ischemia, glycolytic rates in the diabetic rat heart appear to fall below a minimal acceptable level, particularly in the presence of high concentrations of fatty acids. In contrast, fatty acid inhibition of glucose oxidation during reperfusion is less critical in diabetic rat hearts than in non-diabetic control rats. The reason for the differences between diabetic and control hearts has not yet been determined. Differences in metabolic control of myocardial pH and Ca 2q handling may partly explain these effects. 
Myocardial calcium handling during ischemia in the diabetic heart
Accumulation of large amounts of intracellular Ca 2q in the myocardium appears to be of primary importance in w x the initiation of irreversible cell damage 55-57 . shown that sarcolemmal SL Na -K -ATPase and CaATPase, SL Ca 2q channel activity, SL Na q rCa 2q ex-Ž . 2q change, and sarcoplasmic reticulum SR Ca -ATPase Ž activity are all depressed in diabetic hearts see Refs. w x w x . 14,17 and 65 for reviews . During ischemia, most of the myocyte's ATP requirements is produced from anaerobic glycolysis. Therefore, low glycolytic rates in the diabetic heart may accelerate Ca 2q accumulation during ischemia. Little is known, however, concerning the involvement of glycolysis on Ca 2q accumulation during ischemia, particularly in the diabetic. w x Studies by Tani and Neely 35 have suggested that alterations in sarcolemmal Ca 2q transport systems in the diabetic myocardium may actually be beneficial to the heart during reperfusion following ischemia. If acutely diabetic rat hearts were reperfused following a period of no-flow ischemia, they recovered to a greater extent than control hearts, which was highly correlated to a reduced Ca 2q -uptake. These authors suggested that a reduced activity of the Na q rCa 2q exchanger may be responsible, the theory being that increases in intracellular Na q that accumulate during ischemia could not as readily exchange for Ca 2q due to the defective exchanger activity in diabetic w x rats. In subsequent studies 60-62 , these authors demonstrated in non-diabetic rat hearts that high rates of glycolysis during ischemia result in an accumulation of H q which exchanges for Na q via the Na w x As discussed, the study by Tani and Neely 35 was the Ž first to show an increased resistance of diabetic alloxan . and streptozotocin rat hearts to whole-heart ischemia in vitro. When ischemia was maintained for 30 min at 378C, diabetic hearts recovered 100% whereas hearts from normal animals recovered 30% of their preischemic function Ž . i.e., developed pressure = heart rate product . This was associated with 4 times less Ca 2q uptake during reperfu-Ž . sion and less increase in diastolic pressure in diabetic hearts than in control hearts. When the ischemic period was extended, diabetic hearts had a depressed recovery of ventricular function and a greater Ca 2q overload, but reperfusion function was still significantly higher and Ca 2q overload significantly less than in control hearts. Moreover, when the diabetic animals were treated with insulin 2 days prior to removal of the heart, the response to 30 min exposure to ischemia was similar to that of hearts from normal rats. The same authors subsequently showed that the myocardial level of intracellular Na q after 2 min of reperfusion was linearly correlated with Ca 2q uptake and depression of ventricular function during subsequent reperfusion.
A reduction in Ca 2q influx in diabetic hearts may, at least partly, and indirectly, result from a smaller H q load during the ischemic period, and consequently to less activation of Na q -dependent pH regulatory mechanisms. Ali ternatively or together, it may also result from a decreased activity of some pH regulatory mechanism involving Na q w x also occur via lactate-H co-transport 78 . However, the sarcolemmal L-lactate carrier whose kinetics have been determined in single heart cells from rat and guinea-pig w x hearts 79 may also be rapidly inhibited during ischemia. Inhibition may occur through either or both reduced transw x membrane lactate and pH gradient 79 . In this regard, at least the transmembrane lactate gradient should be reduced during ischemia in diabetic hearts in comparison to normal hearts. Diabetic hearts have been shown to accumulate less lactate at the end of ischemia, probably in relation to the w x significant decrease in glycolytic flux 28,68 . This does not appear to affect the decrease in pH , at least during a i w x zero-flow ischemic period 69,80 . On the other hand, intracellular pH regulation via the degree of activation of specific sarcolemmal regulatory mechanisms may play a major role in the recovery of myocardial pH from ischemia, and in the recovery of i myocardial contractility. The initial work by Khandoudi et w x al. 69 , which compared pH data from streptozotocin-ini duced diabetic rat hearts with reduced activity of thew x Na rH exchange process 81,82 versus normal hearts with pharmacological block of the exchanger, has provided support for a critical role of the Na q rH q exchanger in the early stage of reperfusion. In addition, inhibition of the w x function of this transporter, either in diabetic hearts 69 or w x by amiloride and its analogues in normal hearts 62,83,84 , improved the recovery of cardiac contractility after reperfusion.
Further work investigated the contribution of other specific sarcolemmal transport mechanisms of pH recovery i in diabetic rat hearts, and their relation to recovery of w x ventricular function 80 . One such transport mechanism may be H q -lactate co-efflux. Since the tissue lactate accumulated at the end of ischemia was significantly less in w x diabetic hearts than in normal hearts 65,80 , less stimulation of this system would be expected, which may contribute to the slower pH recovery in diabetic hearts at the i w x w x very beginning of reperfusion 80 . This study 80 This discussion has emphasized the significant decrease in Na q rH q exchange activity as an important component of the protection observed in the diabetic heart following an episode of ischemia-reperfusion. Although the results are clear-cut, several limitations to the conclusion on the determining role of Na q rH q exchange have to be taken into account. One is the duration of diabetes. Most of the studies mentioned have used relatively short-term diabetic Ž animals i.e., 3-4 weeks after the injection of streptozo-. tocin . So far, there are no data available on the activity of the Na q rH q exchanger in relation to the progress of diabetes. Such information would be of importance in relation to susceptibility to ischemia-reperfusion injury. Another important aspect is the duration and severity of ischemia. With respect to the extracellular H q inactivation of Na q rH q exchange, the latter will in fact depend on the degree of ischemia and on a residual proton washout of the extracellular space.
It should also be pointed out that most of the pH i studies reported here were not performed in the presence of the high levels of fatty acids that are seen in the uncontrolled diabetic rat. Nevertheless, it has recently been w x shown 29 that isolated working hearts from chronic diabetic rats that received a high level of palmitate are also less sensitive to low-flow ischemic injury than hearts from normal rats. One remaining question concerns the influence of available metabolic substrate, and the preferential stimulation of one or other metabolic pathway, on pH i decrease during ischemia and recovery on reperfusion. To answering this question will obviously be an objective for future studies.
Conclusions
Changes within the myocardium alter the ability of the diabetic heart to recover from an hypoxic or ischemic Research 34 1997 113-120 118 episode. Two important changes that occur in the diabetic heart are alterations in glucose metabolism and pH regulai tion. Based on the existing evidence, we propose that a decrease in glucose uptake and metabolism increases the sensitivity of the diabetic heart to an episode of hypoxia or mild ischemia. In contrast, a decrease in glycolytic product Ž q . accumulation lactate and H as well as alterations in the Žcontrol of pH i.e., a decrease in Na rH exchange i . activity make the diabetic heart less sensitive to an episode of severe ischemia. 
